Examination of the tissue specimen revealed an IDH-mutant astrocytoma CNS WHO grade 3 with an O-6 methylguanine-DNA methyltransferase (MGMT) promotor methylation level of 5.5%. The gene discussed is MGMT; the disease is astrocytoma (excluding glioblastoma).